1.
S1 Dataset -
2.
3.
Differences in patient characteristics and process measures.
Secondary treatment effects and study setting interaction effects.
Reasons for testing in the PHS Amsterdam, first RDT, and second RDT studies in the Netherlands, 2020–2021.
4.
5.
6.
7.
Results of Weibull regression models for the interval between last exposure and testing in days–PHS Amsterdam MCT subset.
Results of Weibull regression models for the interval between last exposure and testing in days–first RDT study.
Results of Weibull regression models for the interval between last exposure and testing in days–second RDT study.
List of parameters used for calculations in MINTRISK.
Overview of causing pathogens, vertebrate host animals, arthropod vectors, and geographical distribution of four vector-borne diseases a .
Pathways entered into MINTRISK to assess the introduction risk of each disease.